Ken Griffin’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Ken Griffin’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,306	Closed	-$22K	–	15624
2023 Q2	$22K	Sell	1,306 -3,966,231	-100%	-$52.1M	﹤0.01%	12643
2023 Q1	$34.1M	Sell	3,967,537 -298	-0%	-$2.46K	0.01%	1422
2022 Q4	$34.2M	Buy	3,967,835 +822,584	+26%	+$6.62M	0.01%	1434
2022 Q3	$18.9M	Buy	3,145,251 +2,014	+0.1%	+$10.9K	﹤0.01%	1935
2022 Q2	$17M	Buy	3,143,237 +420,591	+15%	+$2.26M	﹤0.01%	2024
2022 Q1	$12.8M	Buy	2,722,646 +1,830	+0.1%	+$9.56K	﹤0.01%	2581
2021 Q4	$13.4M	Sell	2,720,816 -547	-0%	-$2.7K	﹤0.01%	2586
2021 Q3	$20.7M	Sell	2,721,363 -4,404	-0.2%	-$37.7K	﹤0.01%	1950
2021 Q2	$31.2M	Buy	+2,725,767	New	+$41.4M	0.01%	1568

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Ken Griffin's VECT Position: Q3 2023 in Review

Ken Griffin sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 1,306 shares — an estimated $22K sold.

Ken Griffin first reported a position in VECT in Q2 2021 and held it in 9 quarters. The position peaked at $34.2M in Q4 2022. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Ken Griffin reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Ken Griffin sold 1,306 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $22K.
Ken Griffin first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 9 quarters.
Ken Griffin's VectivBio Holding AG Ordinary Shares position peaked at $34.2M in Q4 2022.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.